…
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications. It operates in two divisions, Photonics and Medical. The company offers solid-state lasers, laser diodes and components, fiber lasers and amplifiers, and high-power fiber lasers; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military lasers rangefinders, and medical and ophthalmological solutions. Its products are used in various applications, such as defense and space, environment, topography and safety, industry and science, and science and healthcare industries. The company was incorporated in 1970 and is headquartered in Lannion, France. Lumibird SA is a subsidiary of ESIRA.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | - | 6.53M | 7.45M | 14.44M | 17.60M |
| Net income | 12.21M | 5.70M | 7.13M | 11.35M | 13.86M |
| Gross profit | - | 13.12M | 17.25M | 15.36M | 18.49M |
| Ebit | - | 12.79M | 11.64M | 17.78M | 19.86M |
| Ebitda | 22.42M | 31.03M | 27.31M | 32.09M | 31.90M |
| Depreciation and amortization | - | 18.24M | 15.67M | 14.30M | 12.03M |
| Operating income | 22.42M | 14.99M | 18.50M | 16.37M | 19.78M |
| Other operating expenses | 174.39M | 198.49M | 185.06M | 174.59M | 142.69M |
| Interest expense | - | 6.26M | 4.19M | 3.34M | 2.26M |
| Income tax expense | - | 0.83M | 0.33M | 3.08M | 3.75M |
| Total revenue | 196.81M | 207.12M | 203.56M | 190.96M | 162.47M |
| Total operating expenses | 174.39M | -1.87M | -1.24M | -1.01M | -1.28M |
| Cost of revenue | - | 194.00M | 186.30M | 175.60M | 143.97M |
| Total other income expense net | -22.42M | -8.46M | -11.04M | -1.94M | -2.17M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 374.16M | 429.80M | 405.25M | 372.04M | 347.62M |
| Intangible assets | - | 69.95M | 12.10M | 53.41M | 47.32M |
| Other current assets | 135.48M | 0.13M | 0.20M | 0.18M | 7.92M |
| Total liab | 194.19M | 228.16M | 207.98M | 174.86M | 162.51M |
| Total stockholder equity | 179.97M | 198.01M | 193.30M | 193.44M | 181.33M |
| Other current liab | 57.49M | 25.25M | 23.78M | 24.32M | 24.07M |
| Common stock | - | 22.47M | 22.47M | 22.47M | 22.47M |
| Retained earnings | - | 5.70M | 6.17M | 10.06M | 11.66M |
| Good will | 61.76M | 72.09M | 72.59M | 69.94M | 70.26M |
| Other assets | - | - | 0.00M | 0.00M | - |
| Cash | 53.74M | 71.13M | 56.20M | 61.68M | 97.13M |
| Total current liabilities | 76.51M | 79.48M | 74.10M | 119.84M | 57.94M |
| Current deferred revenue | - | 17.17M | 13.27M | 10.99M | 5.63M |
| Net debt | 73.80M | 89.93M | 88.88M | 52.50M | 14.90M |
| Short term debt | 19.02M | 19.04M | 16.48M | 65.56M | 14.17M |
| Short long term debt total | 127.54M | 161.06M | 145.08M | 114.18M | 112.03M |
| Other stockholder equity | 179.97M | 78.65M | 73.19M | 72.44M | 71.84M |
| Total current assets | 189.22M | 208.69M | 197.26M | 187.13M | 182.87M |
| Short term investments | - | - | 0.12M | 0.18M | - |
| Net receivables | - | 58.85M | 62.57M | 58.77M | 39.60M |
| Inventory | - | 78.58M | 78.30M | 66.50M | 46.14M |
| Accounts payable | - | 18.03M | 17.59M | 18.11M | 13.19M |
| Accumulated other comprehensive income | - | 96.89M | 91.47M | 88.47M | 75.35M |
| Non currrent assets other | 184.94M | 11.48M | 60.38M | 11.93M | 7.62M |
| Non current assets total | 184.94M | 221.11M | 207.98M | 184.92M | 164.75M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total cashflows from investing activities | -13.87M | -22.84M | -46.15M | -29.34M | -28.63M |
| Total cash from financing activities | -9.33M | 3.39M | 21.69M | -7.89M | 18.20M |
| Net income | 12.21M | 5.70M | 7.13M | 11.35M | 13.86M |
| Change in cash | -8.32M | 15.00M | -5.48M | -35.45M | 16.80M |
| Begin period cash flow | 62.06M | 56.20M | 61.68M | 97.13M | 80.33M |
| End period cash flow | 53.74M | 71.13M | 56.20M | 61.68M | 97.13M |
| Total cash from operating activities | 20.15M | 34.37M | 20.67M | 1.43M | 26.57M |
| Depreciation | - | 18.24M | 15.67M | 14.30M | 12.03M |
| Other cashflows from investing activities | 0.17M | - | - | - | -0.00M |
| Sale purchase of stock | - | -0.76M | -3.16M | -1.41M | - |
| Other cashflows from financing activities | 5.15M | - | -46.15M | -29.34M | -28.63M |
| Capital expenditures | 14.05M | 22.96M | 25.55M | 29.45M | 20.11M |
| Change in working capital | -13.61M | 5.27M | -4.77M | -29.18M | -8.83M |
| Stock based compensation | - | - | -31.34M | 1.32M | 1.33M |
| Other non cash items | 21.55M | 6.83M | 6.82M | 2.95M | 6.75M |
| Free cash flow | 6.11M | 11.41M | -4.89M | -28.02M | 6.47M |
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| 0FRI Lumibird S.A. |
-0.15 0.63% |
23.60 | 1.13 | - | 1.53 | - |
| 0R15 SoftBank Group Corp. |
248.00 5.84% |
4494.00 | - | - | - | - |
| 0R1E Nintendo Co. Ltd. |
-115.00 1.34% |
8476.00 | - | - | - | - |
| 0LC3 Synchrony Financial |
2.34 3.20% |
75.60 | 0.09 | - | 4.97 | - |
| 0HQP CBRE Group Inc. Cl A |
0.15 0.12% |
122.47 | 0.25 | - | 1.18 | - |
Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications. It operates in two divisions, Photonics and Medical. The company offers solid-state lasers, laser diodes and components, fiber lasers and amplifiers, and high-power fiber lasers; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military lasers rangefinders, and medical and ophthalmological solutions. Its products are used in various applications, such as defense and space, environment, topography and safety, industry and science, and science and healthcare industries. The company was incorporated in 1970 and is headquartered in Lannion, France. Lumibird SA is a subsidiary of ESIRA.
| Name | Title | Year Born |
|---|---|---|
| Dr. Marc Le Flohic | CEO & Chairman | 1963 |
| Ms. Sonia Rutnam | Group Secretary General and Director of General Finance & Information Systems | NA |
| Mr. Alexandre Billard | Purchasing Director & Sales Director | NA |
| Mr. Nicolas Ballif | Director of Human Resources | NA |
| Mr. Philippe Metivier | Director of Research & Development | 1961 |
| Mr. Frederic Chiquet | Chief Corporate Social Responsibility Officer | NA |
| Mr. Nigel Holehouse | Program Director | NA |
| Mr. Pierre-Franasois Chenevier | Deputy General Director & General Director of Photonics Division | NA |
| Mr. Jean-Marc Gendre | Deputy General Director & CEO of Lumibird Medical | NA |
| Ms. Aude Nomblot-Gourhand | Financial Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.